Regulatory Considerations for Building an In Silico Clinical Pharmacology Backbone by 2030

Efthymios Manolis, Flora Musuamba Tshinanu, Kristin E. Karlsson

Résultats de recherche: Contribution à un journal/une revue › Article › Revue par des pairs

langue originale	Anglais
Pages (de - à)	746-748
Nombre de pages	3
journal	Clinical Pharmacology and Therapeutics
Volume	107
Numéro de publication	4
Les DOIs	https://doi.org/10.1002/cpt.1772
Etat de la publication	Publié - 1 avr. 2020
Modification externe	Oui

Accès au document

@article{e5c72cb1a5fa4a868e8b692ab01c0a45,

title = "Regulatory Considerations for Building an In Silico Clinical Pharmacology Backbone by 2030",

author = "Efthymios Manolis and {Musuamba Tshinanu}, Flora and Karlsson, {Kristin E.}",

year = "2020",

month = apr,

day = "1",

doi = "10.1002/cpt.1772",

language = "English",

volume = "107",

pages = "746--748",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Regulatory Considerations for Building an In Silico Clinical Pharmacology Backbone by 2030

AU - Manolis, Efthymios

AU - Musuamba Tshinanu, Flora

AU - Karlsson, Kristin E.

PY - 2020/4/1

Y1 - 2020/4/1

UR - http://www.scopus.com/inward/record.url?scp=85078896235&partnerID=8YFLogxK

U2 - 10.1002/cpt.1772

DO - 10.1002/cpt.1772

M3 - Article

C2 - 32010966

AN - SCOPUS:85078896235

SN - 0009-9236

VL - 107

SP - 746

EP - 748

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 4

ER -